Back to Search
Start Over
Serum 5'-nucleotidase of a breast cancer patient.
- Source :
-
Clinical biochemistry [Clin Biochem] 1980 Feb; Vol. 13 (1), pp. 51-4. - Publication Year :
- 1980
-
Abstract
- Serum derived from the breast cancer patient included in this study was found to be a rich source of 5'-nucleotidase. In addition, it also contains nonspecific alkaline phosphatase. The properties of 5'-nucleotidase were studied by eliminating the interference of serum non-specific alkaline phosphatase by the preliminary incubation of serum in glycine-NaOH buffer containing ethylenediamine tetraacetate and magnesium. The enzyme has a pH optimum at 9.5. It is remarkably stable when held at 50 degrees C at pH 7.5, but it readily lost activity in the acid medium at pH 4.2. It hydrolyzes both the ribo- and deoxyribo-nucleoside 5'-phosphates. It has the highest preference for cytidine 5'-phosphate. Adenosine 2'- or 3'- phosphates are refractory to its action.
- Subjects :
- 5'-Nucleotidase
Adenosine Monophosphate metabolism
Alkaline Phosphatase antagonists & inhibitors
Alkaline Phosphatase blood
Drug Stability
Edetic Acid pharmacology
Female
Humans
Hydrogen-Ion Concentration
Kinetics
Magnesium pharmacology
Middle Aged
Substrate Specificity
Breast Neoplasms enzymology
Nucleotidases blood
Subjects
Details
- Language :
- English
- ISSN :
- 0009-9120
- Volume :
- 13
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Clinical biochemistry
- Publication Type :
- Academic Journal
- Accession number :
- 6244908
- Full Text :
- https://doi.org/10.1016/s0009-9120(80)90602-5